Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
Archives: Search / 2024 / 2023 / 2022 / 2021 / 2020 / 2019 / 2018 / 2017 / 2016 / 2015 / 2014 / 2013
2021 Archives
Dec 21, 2021 Dario solutions being offered as part of new premier benefits product designed for small business market DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced a new strategic partnership with a leading employer benefits brokerage (the "Partner") to sell... |
Dario now counts more than 50 clients across multi-chronic condition platform solutions DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced new contracts today to provide its highly personalized digital therapeutics beginning in the... |
Dario now counts 49 clients across multi-chronic condition platform solutions to date as demand continues to grow DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has contracted with two employers to provide its highly personalized digital... |
Strong B2B new contract growth results in total of 47 signed accounts - 85% achieved in the last two quarters DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the third quarter of 2021 and provided a corporate and commercial... |
Newly created role will support the accelerating growth of Dario as a leader in the digital therapeutics market DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the Company appointed Jerrod Helms to the newly created role of Chief Commercial Officer... |
Dario Now Claims 20 New Contracts in the Last Six Months DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has contracted with two new employers and a new provider partner channel to... |
Company to host conference call and webcast on Tuesday, November 16, at 8:30 am ET DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the third quarter ended September 30, 2021 on... |
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that management will participate at the following conferences: Credit Suisse 30th Annual... |
New partnership makes Dario's full suite of digital therapeutics available to National Group Benefits Platform's large population of employers DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today a new strategic partnership with a leading national benefits administrative platform... |
Dario Expands Provider Footprint to Georgia and Hawaii DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into contracts with two prominent regional providers in Hawaii and... |
Virgin Pulse clients can expand their Homebase for Health® with multi-condition digital therapeutic and health solutions through DarioHealth DarioHealth today announced it has partnered with Virgin Pulse, the leading global provider of digital and live health and wellbeing solutions, making its next-gen digital therapeutic and health... |
Dario Achieves a Significant Milestone with First Contract for Full Suite of Solutions DarioHealth Corp. ("Dario," "DarioHealth" or the "Company") (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into a contract with a... |
- New Product Significantly Expands Impact and Value of Dario's Integrated Digital Therapeutics Platform DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today the launch of Dario Move, a new digital physical therapy solution to manage common... |
New Contract Integrates Dario in Health Plan's Behavioral Health Product Serving Millions of Members DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today it has entered into an agreement with one of the largest U.S. national health plans... |
Signals Increasing Demand in the Employer Market for Integrated Chronic Condition Management Solutions DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today an agreement with a global company based in the United States ("Company") to provide its... |
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that management will participate in a fireside chat during the Cantor Fitzgerald Virtual... |
Dr. Manejwala to Discuss the Application of Digital Innovations in Medicaid Populations DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company's Chief Medical Officer, Dr. Omar Manejwala, will present at the annual... |
Dario Continues to Expand its Employer Contracts Across Broad Range of Solutions NEW YORK, Sept. 9, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital... |
Sep 8, 2021 Dario Continues Strong Expansion in Employer Market Leveraging Broad Product Platform DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into an agreement to provide its digital behavioral health platform... |
Dario Continues Strong Expansion in Provider Market Leveraging Broad Product Platform DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has been selected by regional primary care provider PeopleOne Health to be the... |
Total Q2 revenue of $5.3 million increased 46% sequentially and 194% year-over-year DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the second quarter of 2021 and provided a corporate and commercial... |
New Study Presented at American Association of Diabetes Care and Education Specialists Annual Conference Highlights the Clinical Strength of Dario's AI-Driven Journey Engine DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced a new study at the American Association of Diabetes Care and Education Specialists (ADCES)... |
Aug 9, 2021 Company to host conference call and webcast 8:30 am ET DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the second quarter ended June 30, 2021 on Monday,... |
Contract adds to significant growth in the employer market for new behavioral health solution DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has been selected as the digital behavioral health provider by a leading national... |
New Relationship Expands Dario's Global Reach Across Full Suite of Digital Health Solutions DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced the launch of its digital behavioral health solution that now includes Workplace Options... |
1-25 26-50 51-53 |